Blocking the PI3K/PKB Pathway in Tumor Cells

Publisher： Bentham Science Publishers

E-ISSN： 1875-5968|5|5|449-462

ISSN： 1568-0118

Source： Current Medicinal Chemistry - Anti-Cancer Agents, Vol.5, Iss.5, 2005-09, pp. : 449-462

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

12-Deoxyphorbol 13-palmitate inhibits the expression of VEGF and HIF-1α in MCF-7 cells by blocking the PI3K/Akt/mTOR signaling pathway

By            

Oncology Reports, Vol. 34, Iss. 4, 2015-01 ,pp. : 1755-1760

Spandidos Publications

Access to resources Recommend Favorite

Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells

By      

International Journal of Oncology, Vol. 46, Iss. 6, 2015-01 ,pp. : 2355-2363

Spandidos Publications

Access to resources Recommend Favorite

Evodiamine inhibits the proliferation of human osteosarcoma cells by blocking PI3K/Akt signaling

By                        

Oncology Reports, Vol. 34, Iss. 3, 2015-01 ,pp. : 1388-1396

Spandidos Publications

Access to resources Recommend Favorite

Shikonin promotes autophagy in BXPC3 human pancreatic cancer cells through the PI3K/Akt signaling pathway

By    

Oncology Letters, Vol. 8, Iss. 3, 2014-01 ,pp. : 1087-1089

Spandidos Publications

Access to resources Recommend Favorite

Jolkinolide B induces apoptosis in MDA-MB-231 cells through inhibition of the PI3K/Akt signaling pathway

By              

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 1976-1980

Spandidos Publications

Access to resources Recommend Favorite